Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
![JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study | HTML JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study | HTML](https://www.mdpi.com/jpm/jpm-12-00727/article_deploy/html/images/jpm-12-00727-g001.png)
JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study | HTML
![Daniel CASTELLANO | Hospital Universitario 12 de Octubre, Madrid | 12OCTUBRE | Medical Oncology Department Daniel CASTELLANO | Hospital Universitario 12 de Octubre, Madrid | 12OCTUBRE | Medical Oncology Department](https://i1.rgstatic.net/ii/profile.image/864677676457984-1583166631246_Q512/Daniel-Castellano.jpg)
Daniel CASTELLANO | Hospital Universitario 12 de Octubre, Madrid | 12OCTUBRE | Medical Oncology Department
![Adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia. - ppt download Adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia. - ppt download](https://slideplayer.com/9155409/27/images/slide_1.jpg)
Adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia. - ppt download
![Gaetano PEZZICOLI | Medical Doctor | Doctor of Medicine | Università degli Studi di Bari Aldo Moro, Bari | Università di Bari | Dipartimento di Scienze Biomediche ed Oncologia Umana (DIMO) Gaetano PEZZICOLI | Medical Doctor | Doctor of Medicine | Università degli Studi di Bari Aldo Moro, Bari | Università di Bari | Dipartimento di Scienze Biomediche ed Oncologia Umana (DIMO)](https://i1.rgstatic.net/ii/profile.image/1069256951209984-1631942131234_Q512/Gaetano-Pezzicoli-2.jpg)
Gaetano PEZZICOLI | Medical Doctor | Doctor of Medicine | Università degli Studi di Bari Aldo Moro, Bari | Università di Bari | Dipartimento di Scienze Biomediche ed Oncologia Umana (DIMO)
Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey | PLOS ONE
![Francesco ATZORI | Attending Phisician | Doctor of Medicine | Università degli studi di Cagliari, Cagliari | UNICA | Azienda Ospedaliero-Universitaria di Cagliari Francesco ATZORI | Attending Phisician | Doctor of Medicine | Università degli studi di Cagliari, Cagliari | UNICA | Azienda Ospedaliero-Universitaria di Cagliari](https://i1.rgstatic.net/ii/profile.image/1096678220267524-1638479871914_Q512/Francesco-Atzori.jpg)
Francesco ATZORI | Attending Phisician | Doctor of Medicine | Università degli studi di Cagliari, Cagliari | UNICA | Azienda Ospedaliero-Universitaria di Cagliari
![Nicola SILVESTRIS | Full professor | Professor | Università degli Studi di Messina, Messina | UNIME - Page 4 Nicola SILVESTRIS | Full professor | Professor | Università degli Studi di Messina, Messina | UNIME - Page 4](https://i1.rgstatic.net/ii/profile.image/394509356683264-1471069768460_Q512/Nicola-Silvestris.jpg)
Nicola SILVESTRIS | Full professor | Professor | Università degli Studi di Messina, Messina | UNIME - Page 4
![Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting | Future Oncology Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.14.48/asset/images/medium/figure2.gif)
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting | Future Oncology
![Alessandro RIZZO | Medical Doctor | Ospedale Oncologico "Giovanni Paolo II" di Bari, Bari | IRCCS Bari | Department of Medical Oncology Alessandro RIZZO | Medical Doctor | Ospedale Oncologico "Giovanni Paolo II" di Bari, Bari | IRCCS Bari | Department of Medical Oncology](https://i1.rgstatic.net/ii/profile.image/977348979589124-1610029563829_Q512/Alessandro-Rizzo-4.jpg)